1. Home
  2. BRTX vs FBGL Comparison

BRTX vs FBGL Comparison

Compare BRTX & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • FBGL
  • Stock Information
  • Founded
  • BRTX 1997
  • FBGL 1996
  • Country
  • BRTX United States
  • FBGL Singapore
  • Employees
  • BRTX N/A
  • FBGL N/A
  • Industry
  • BRTX Managed Health Care
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • BRTX Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • BRTX Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • BRTX 12.2M
  • FBGL 12.4M
  • IPO Year
  • BRTX N/A
  • FBGL 2025
  • Fundamental
  • Price
  • BRTX $1.71
  • FBGL $0.59
  • Analyst Decision
  • BRTX Strong Buy
  • FBGL
  • Analyst Count
  • BRTX 1
  • FBGL 0
  • Target Price
  • BRTX $18.00
  • FBGL N/A
  • AVG Volume (30 Days)
  • BRTX 34.3K
  • FBGL 488.1K
  • Earning Date
  • BRTX 05-13-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • BRTX N/A
  • FBGL N/A
  • EPS Growth
  • BRTX N/A
  • FBGL N/A
  • EPS
  • BRTX N/A
  • FBGL 0.04
  • Revenue
  • BRTX $401,000.00
  • FBGL $15,607,369.00
  • Revenue This Year
  • BRTX $446.88
  • FBGL N/A
  • Revenue Next Year
  • BRTX $39.53
  • FBGL N/A
  • P/E Ratio
  • BRTX N/A
  • FBGL $15.96
  • Revenue Growth
  • BRTX 175.03
  • FBGL 25.78
  • 52 Week Low
  • BRTX $1.03
  • FBGL $0.44
  • 52 Week High
  • BRTX $2.55
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 46.37
  • FBGL N/A
  • Support Level
  • BRTX $1.64
  • FBGL N/A
  • Resistance Level
  • BRTX $1.78
  • FBGL N/A
  • Average True Range (ATR)
  • BRTX 0.10
  • FBGL 0.00
  • MACD
  • BRTX -0.01
  • FBGL 0.00
  • Stochastic Oscillator
  • BRTX 42.82
  • FBGL 0.00

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial and industrial building projects. As a green contractor focused on environmentally sound practices, It aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, lead lining, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts, sales of construction materials, and rendering of services.

Share on Social Networks: